Literature DB >> 11238843

Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.

E Blanco1, M Garcia-Briones, A Sanz-Parra, P Gomes, E De Oliveira, M L Valero, D Andreu, V Ley, F Sobrino.   

Abstract

Porcine T-cell recognition of foot-and-mouth disease virus (FMDV) nonstructural proteins (NSP) was tested using in vitro lymphoproliferative responses. Lymphocytes were obtained from outbred pigs experimentally infected with FMDV. Of the different NSP, polypeptides 3A, 3B, and 3C gave the highest stimulations in the in vitro assays. The use of overlapping synthetic peptides allowed the identification of amino acid regions within these proteins that were efficiently recognized by the lymphocytes. The sequences of some of these antigenic peptides were highly conserved among different FMDV serotypes. They elicited major histocompatibility complex-restricted responses with lymphocytes from pigs infected with either a type C virus or reinfected with a heterologous FMDV. A tandem peptide containing the T-cell peptide 3A[21-35] and the B-cell antigenic site VP1[137-156] also efficiently stimulated lymphocytes from infected animals in vitro. Furthermore, this tandem peptide elicited significant levels of serotype-specific antiviral activity, a result consistent with the induction of anti-FMDV antibodies. Thus, inclusion in the peptide formulation of a T-cell epitope derived from the NSP 3A possessing the capacity to induce T helper activity can allow cooperative induction of anti-FMDV antibodies by B cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238843      PMCID: PMC114110          DOI: 10.1128/JVI.75.7.3164-3174.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Studies on antigenic variability of C strains of foot-and-mouth disease virus by means of synthetic peptides and monoclonal antibodies.

Authors:  C Carreño; X Roig; J Cairo; J Camarero; M G Mateu; E Domingo; E Giralt; D Andreu
Journal:  Int J Pept Protein Res       Date:  1992-01

Review 2.  New approaches to vaccination against foot-and-mouth disease.

Authors:  F Brown
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

3.  Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4).

Authors:  E Celis; J Larson; L Otvos; W H Wunner
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

4.  A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle.

Authors:  T Collen; R Dimarchi; T R Doel
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

Review 5.  Developments in foot-and-mouth disease vaccines.

Authors:  S J Barteling; J Vreeswijk
Journal:  Vaccine       Date:  1991-02       Impact factor: 3.641

6.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.

Authors:  M Del Val; H J Schlicht; T Ruppert; M J Reddehase; U H Koszinowski
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

7.  Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization.

Authors:  D M Shaw; C M Stanley; C D Partidos; M W Steward
Journal:  Mol Immunol       Date:  1993-08       Impact factor: 4.407

8.  Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection.

Authors:  M Toja; C Escarmís; E Domingo
Journal:  Virus Res       Date:  1999-11       Impact factor: 3.303

9.  Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein.

Authors:  C J Hackett; D Horowitz; M Wysocka; S B Dillon
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

10.  Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins.

Authors:  J C Sáiz; A Rodríguez; M González; F Alonso; F Sobrino
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

View more
  26 in total

1.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

Review 2.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

3.  Comparative complete genome analysis of Indian type A foot-and-mouth disease virus field isolates.

Authors:  Saravanan Subramaniam; Aniket Sanyal; Jajati K Mohapatra; Divakar Hemadri; Bramhadev Pattnaik
Journal:  Virus Genes       Date:  2011-05-22       Impact factor: 2.332

4.  Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.

Authors:  Sultan Gülçe İz; Mert Döşkaya; Belen Borrego; Fernando Rodriguez; Yüksel Gürüz; Ismet Deliloğlu Gürhan
Journal:  Vet Res Commun       Date:  2013-03-13       Impact factor: 2.459

5.  Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination.

Authors:  Efrain Guzman; Geraldine Taylor; Bryan Charleston; Shirley A Ellis
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

6.  Comparative genomics of foot-and-mouth disease virus.

Authors:  C Carrillo; E R Tulman; G Delhon; Z Lu; A Carreno; A Vagnozzi; G F Kutish; D L Rock
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle.

Authors:  Nicholas Juleff; Miriam Windsor; Eric A Lefevre; Simon Gubbins; Pip Hamblin; Elizabeth Reid; Kerry McLaughlin; Peter C L Beverley; Ivan W Morrison; Bryan Charleston
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.

Authors:  Huiying Fan; Tiezhu Tong; Huanchun Chen; Aizhen Guo
Journal:  Virus Genes       Date:  2007-05-12       Impact factor: 2.332

9.  Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide.

Authors:  Carolina Cubillos; Beatriz G de la Torre; Annamaria Jakab; Giorgia Clementi; Eva Borrás; Juan Bárcena; David Andreu; Francisco Sobrino; Esther Blanco
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

10.  Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus.

Authors:  Felix N Toka; Charles Nfon; Harry Dawson; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2009-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.